wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738985-25B0FA0D-BA5E-4DF4-979C-A42E6042D071
Q26738985-25B0FA0D-BA5E-4DF4-979C-A42E6042D071
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738985-25B0FA0D-BA5E-4DF4-979C-A42E6042D071
Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer
P2860
Q26738985-25B0FA0D-BA5E-4DF4-979C-A42E6042D071
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738985-25B0FA0D-BA5E-4DF4-979C-A42E6042D071
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a76eb38c6f7bcda357209495272093ef248a4349
P2860
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.